932706-26-8

Basic information

• Product Name: benzyl N-[(1R,3S)-3-fluorocyclopentyl]carbaMate
• Synonyms: benzyl N-[(1R,3S)-3-fluorocyclopentyl]carbaMate;benzyl N-[(1S,3R)-3-fluorocyclopentyl]carbamate;Cis-benzyl (3-fluorocyclopentyl)carbamate(WXC00138)
• CAS NO: 932706-26-8
• Molecular Formula: C₁₃H₁₆FNO₂
• Molecular Weight: 237.2700432
• Mol File: 932706-26-8.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: benzyl N-[(1R,3S)-3-fluorocyclopentyl]carbaMate(CAS DataBase Reference)
• NIST Chemistry Reference: benzyl N-[(1R,3S)-3-fluorocyclopentyl]carbaMate(932706-26-8)
• EPA Substance Registry System: benzyl N-[(1R,3S)-3-fluorocyclopentyl]carbaMate(932706-26-8)

Safety Data

• Hazardous Substances Data: 932706-26-8(Hazardous Substances Data)

Upstream product

• 501-53-1 benzyl chloroformate 
• 939426-84-3 benzyl (trans-3-hydroxycyclopentyl)carbamate 
• 932706-25-7 (1S,3S)-1-{[(benzyloxy)carbonyl]amino}-3-[(methylsulfonyl)oxy]cyclopentane 

Downstream Products

• 932706-21-3 (1S, 3R)-3-fluorocyclopentanamine hydrochloride 

Relevant articles and documents

Novel Imidazo[4,5-c]Quinoline And Imidazo[4,5-c][1,5]Naphthyridine Derivatives As LRRK2 Inhibitors

The present invention provides novel imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives of Formula (I), and the pharmaceutically acceptable salts thereof wherein R1, R1a, R1b, R2, R4, R5, R6, X and Z are as defined in the specification. The invention is also directed to pharmaceutical compositions comprising the compounds of Formula (I) and to use of the compounds in the treatment of diseases associated with LRRK2, such as neurodegenerative diseases including Parkinson's disease or Alzheimer's disease, cancer, Crohn's disease or leprosy.